Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest…

Overview of attention for article published in Journal of Clinical Oncology, July 2003

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy: 2 policy sources
patent: 5 patents

guideline: 3 clinical guideline sources

Readers on

mendeley: 119 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

METHODS FOR TREATING CANCERS USING GM-CSF ENCODING POLYNUCLEOTIDE AND ADDITIONAL AGENTS

Application WO-2021146213-A1

World Intellectual Property Organisation (WIPO)

22 Jul 2021

Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their…

Grant US-9504738-B2

United States of America

29 Nov 2016

Chimeric peptides comprising HER-2 B-cell epitopes and Tcell helper epitopes

Grant US-9452204-B2

United States of America

27 Sep 2016

Chimeric peptides comprising HER-2 B-cell epitopes and T-helper epitopes

Grant US-8470333-B2

United States of America

25 Jun 2013

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.